Gout drug tapering study: less medicine, same control?
NCT ID NCT06622603
First seen Apr 30, 2026 · Last updated May 23, 2026 · Updated 5 times
Summary
This study looks at whether people with well-controlled gout (for 5 years or more) can take a lower dose of febuxostat or even stop it without their uric acid levels rising or symptoms coming back. About 59 adults will be split into three groups: one that reduces the dose, one that stops for 6 months then restarts a low dose, and one that stays on their current treatment. The goal is to see if less medication can still keep uric acid under 7.0 mg/dL.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GOUT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Seoul National University Bundang Hospital
RECRUITINGSeongnam-si, Gyeonggi-do, 463-707, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.